Tissue carcinoembryonic antigen and oestrogen receptor status in breast carcinoma: an immunohistochemical study of clinical outcome in a series of 252 patients with long-term follow-up

British Journal of Cancer
F A MauriM Barbareschi

Abstract

Carcinoembryonic antigen (CEA) is a well-known tumour marker whose immunohistochemical expression could be prognostically relevant in breast carcinomas. We evaluated CEA immunohistochemical expression, using the specific T84.66 monoclonal antibody, in a series of 252 consecutive cases of infiltrating breast carcinomas (104 N0, 148 N1/2) with median follow-up of 84 months. Oestrogen receptor (ER) status has been evaluated with the immunohistochemical method (ER1D5 antibody, 10% cut-off value): 121 cases were ER negative, 128 cases were ER positive and in three cases ER status was unknown. CEA staining was cytoplasmic; staining intensity and percentage of reacting cells were combined to obtain a final score (CEA score). The difference between the distribution of CEA score within the modalities of the other variables was not statistically significant. Univariate survival analysis has been performed on the series of node-negative and node-positive patients. In the latter subgroup, this has been performed separately for patients treated with systemic adjuvant hormonal therapy or chemotherapy. A multivariate analysis was only performed for node-positive patients treated with adjuvant therapy. CEA immunoreactivity was not prognostical...Continue Reading

Citations

Dec 2, 2015·Oncology Letters·Marie N NickelsenSteffen Heegaard
Nov 24, 2012·The British Journal of Surgery·S SaadatmandP J K Kuppen
May 26, 1999·The Journal of Pathology·D Jones, C D Fletcher
Apr 4, 2003·International Journal of Cancer. Journal International Du Cancer·Dirk NagorsenUlrich Keilholz
Oct 13, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·S KobayashiH Iwase
Dec 5, 2006·International Journal of Colorectal Disease·Wan-Yi KangChee-Yin Chai
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sze Chuen Cesar WongW L Wendy Hsiao
Nov 17, 2020·Oncotarget·Marc B BechmannRené Villadsen
Feb 3, 2000·Archives of Pathology & Laboratory Medicine·M Devouassoux-ShisheboranF A Tavassoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.